<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Shah VV</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Recent findings suggest that a single gait assessment in a clinic may not reflect everyday mobility.&lt;h4>Objective&lt;/h4>We compared gait measures that best differentiated individuals with spinocerebellar ataxia (SCA) from age-matched healthy controls (HC) during a supervised gait test in the clinic vs. a week of unsupervised gait during daily life.&lt;h4>Methods&lt;/h4>Twenty-six individuals with SCA types 1, 2, 3, and 6, and 13 (HC) wore three Opal inertial sensors (on both feet and lower back) during a 2-minute walk in the clinic and for seven days in daily life. Seventeen gait measures were analyzed to investigate the group differences using Mann-Whitney &lt;i>U&lt;/i>-tests and area under the curve (AUC).&lt;h4>Results&lt;/h4>Ten gait measures were significantly worse in SCA than HC for the clinic test (&lt;i>p&lt;/i> &lt; 0.003), but only 3 were worse in daily life (&lt;i>p&lt;/i> &lt; 0.003). Only a few gait measures consistently discriminated groups in both environments. Specifically, variability in Swing Time and Double Support Time had AUCs of 0.99 (&lt;i>p&lt;/i> &lt; 0.0001) and 0.96 (&lt;i>p&lt;/i> &lt; 0.0001) in the clinic, and 0.84 (&lt;i>p&lt;/i> &lt; 0.0003) and 0.80 (&lt;i>p&lt;/i> &lt; 0.002) in daily life, respectively. Clinical gait measures showed stronger correlations with clinical outcomes (ie, SARA and FARS-ADL; r = 0.50-0.77) than between daily life gait measures (r = 0.31-0.49). Gait activity in daily life was not statistically significant between the SCA and HC groups (&lt;i>p&lt;/i> > 0.06).&lt;h4>Conclusions&lt;/h4>Digital gait measures discriminate SCA in both environments. In-clinic measures are more sensitive, while daily life measures provide ecological validity, highlighting a trade-off and offering complementary insights.</pubmed_abstract><journal>Frontiers in digital health</journal><pagination>1590150</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12440962</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinic vs. daily life gait characteristics in patients with spinocerebellar ataxia.</pubmed_title><pmcid>PMC12440962</pmcid><pubmed_authors>Sowalsky K</pubmed_authors><pubmed_authors>Safarpour D</pubmed_authors><pubmed_authors>Jagodinsky A</pubmed_authors><pubmed_authors>Carlson-Kuhta P</pubmed_authors><pubmed_authors>Shah VV</pubmed_authors><pubmed_authors>El-Gohary M</pubmed_authors><pubmed_authors>McNames J</pubmed_authors><pubmed_authors>Casey H</pubmed_authors><pubmed_authors>Muzyka D</pubmed_authors><pubmed_authors>Gomez CM</pubmed_authors><pubmed_authors>Horak FB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinic vs. daily life gait characteristics in patients with spinocerebellar ataxia.</name><description>&lt;h4>Background&lt;/h4>Recent findings suggest that a single gait assessment in a clinic may not reflect everyday mobility.&lt;h4>Objective&lt;/h4>We compared gait measures that best differentiated individuals with spinocerebellar ataxia (SCA) from age-matched healthy controls (HC) during a supervised gait test in the clinic vs. a week of unsupervised gait during daily life.&lt;h4>Methods&lt;/h4>Twenty-six individuals with SCA types 1, 2, 3, and 6, and 13 (HC) wore three Opal inertial sensors (on both feet and lower back) during a 2-minute walk in the clinic and for seven days in daily life. Seventeen gait measures were analyzed to investigate the group differences using Mann-Whitney &lt;i>U&lt;/i>-tests and area under the curve (AUC).&lt;h4>Results&lt;/h4>Ten gait measures were significantly worse in SCA than HC for the clinic test (&lt;i>p&lt;/i> &lt; 0.003), but only 3 were worse in daily life (&lt;i>p&lt;/i> &lt; 0.003). Only a few gait measures consistently discriminated groups in both environments. Specifically, variability in Swing Time and Double Support Time had AUCs of 0.99 (&lt;i>p&lt;/i> &lt; 0.0001) and 0.96 (&lt;i>p&lt;/i> &lt; 0.0001) in the clinic, and 0.84 (&lt;i>p&lt;/i> &lt; 0.0003) and 0.80 (&lt;i>p&lt;/i> &lt; 0.002) in daily life, respectively. Clinical gait measures showed stronger correlations with clinical outcomes (ie, SARA and FARS-ADL; r = 0.50-0.77) than between daily life gait measures (r = 0.31-0.49). Gait activity in daily life was not statistically significant between the SCA and HC groups (&lt;i>p&lt;/i> > 0.06).&lt;h4>Conclusions&lt;/h4>Digital gait measures discriminate SCA in both environments. In-clinic measures are more sensitive, while daily life measures provide ecological validity, highlighting a trade-off and offering complementary insights.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-03T12:06:50.981Z</modification><creation>2026-04-27T03:11:32.53Z</creation></dates><accession>S-EPMC12440962</accession><cross_references><pubmed>40970140</pubmed><doi>10.3389/fdgth.2025.1590150</doi></cross_references></HashMap>